CLINICAL_TRIALS trial_result · 2024-03-06

Clinical Trial Update: A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia [Phase 2]

Phase 2 clinical trial of mesdopetam in Parkinson's disease patients with levodopa-induced dyskinesia has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Integrative Research Laboratories AB | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-03-06